Correlation Between MEDCAW INVESTMENTS and HANSOH PHARMAC

Can any of the company-specific risk be diversified away by investing in both MEDCAW INVESTMENTS and HANSOH PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MEDCAW INVESTMENTS and HANSOH PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MEDCAW INVESTMENTS LS 01 and HANSOH PHARMAC HD 00001, you can compare the effects of market volatilities on MEDCAW INVESTMENTS and HANSOH PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MEDCAW INVESTMENTS with a short position of HANSOH PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of MEDCAW INVESTMENTS and HANSOH PHARMAC.

Diversification Opportunities for MEDCAW INVESTMENTS and HANSOH PHARMAC

0.0

Correlation Coefficient

MEDCAW INVESTMENTS  HANSOH PHARMAC

Pay attention - limited upside

The 3 months correlation between MEDCAW and HANSOH is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MEDCAW INVESTMENTS LS 01 and HANSOH PHARMAC HD 00001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HANSOH PHARMAC HD and MEDCAW INVESTMENTS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MEDCAW INVESTMENTS LS 01 are associated (or correlated) with HANSOH PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HANSOH PHARMAC HD has no effect on the direction of MEDCAW INVESTMENTS i.e., MEDCAW INVESTMENTS and HANSOH PHARMAC go up and down completely randomly.

Pair Corralation between MEDCAW INVESTMENTS and HANSOH PHARMAC

Assuming the 90 days horizon MEDCAW INVESTMENTS LS 01 is expected to under-perform the HANSOH PHARMAC. In addition to that, MEDCAW INVESTMENTS is 1.32 times more volatile than HANSOH PHARMAC HD 00001. It trades about -0.01 of its total potential returns per unit of risk. HANSOH PHARMAC HD 00001 is currently generating about 0.04 per unit of volatility. If you would invest  138.00  in HANSOH PHARMAC HD 00001 on October 11, 2024 and sell it today you would earn a total of  59.00  from holding HANSOH PHARMAC HD 00001 or generate 42.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

MEDCAW INVESTMENTS LS 01  vs.  HANSOH PHARMAC HD 00001

MEDCAW INVESTMENTS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MEDCAW INVESTMENTS LS 01 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, MEDCAW INVESTMENTS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

HANSOH PHARMAC HD

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HANSOH PHARMAC HD 00001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with MEDCAW INVESTMENTS and HANSOH PHARMAC

The main advantage of trading using opposite MEDCAW INVESTMENTS and HANSOH PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MEDCAW INVESTMENTS position performs unexpectedly, HANSOH PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HANSOH PHARMAC will offset losses from the drop in HANSOH PHARMAC's long position.

The idea behind MEDCAW INVESTMENTS LS 01 and HANSOH PHARMAC HD 00001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.